BioSpace News Archive

Genetown

Jounce Therapeutics to Present Safety and Preliminary Efficacy Data on JTX-4014 and a Trials in Progress Poster for the Vopratelimab EMERGE Study at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting

Introducing the dosing and sequencing strategy for vopratelimab and ipilimumab in ongoing EMERGE Phase 2 trial

November 5, 2019
·
7 min read
Drug Development

BioLineRx Presents Preclinical Data From Triple Combination of BL-8040, Anti PD-1 and Chemotherapy Demonstrating Significant Reduction in Pancreatic Tumor Growth and Favorable Changes in Tumor Microenvironment

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today positive preclinical results further elucidating the mechanism of action of BL-8040 in combination with an anti PD-1 and chemotherapy.

November 5, 2019
·
5 min read
Deals

IRISYS Awarded NIH “Drug Formulation and Manufacturing” Contract for Up To $45 Million

Contract from National Institutes of Health (NIH) is Largest of Four Prime Contracts Awarded IRISYS Since 2010

November 5, 2019
·
2 min read
Drug Development

Cartesian Initiates CAR-T Clinical Trial in Myasthenia Gravis

Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer and autoimmune diseases, today announced that it has initiated a Phase 1/2 clinical trial (NCT04146051) of its lead CAR-T candidate, Descartes-08, in patients with generalized myasthenia gravis (GMG).

November 5, 2019
·
4 min read
Biotech Bay

Bolt Biotherapeutics Announces ISAC Data Presentation At the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Bolt Biotherapeutics, Inc., a private biotechnology company focused on unleashing the power of the immune system to treat cancer, announced the upcoming presentation of preclinical data from its Immune-Stimulating Antibody Conjugate platform at the 34th Annual Meeting of the Society for Immunotherapy of Cancer in National Harbor, Maryland.

November 5, 2019
·
2 min read
Business

Experic Welcomes Niyati Patel as the Director of Quality Assurance and Compliance

Experic, a contract manufacturing organization and pharmaceutical supply service company, announces the hire of Niyati Patel as the director of quality assurance and compliance in October 2019.

November 5, 2019
·
1 min read
Business

Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate

BeiGene and Seattle Genetics to Collaborate on Global Clinical Trials

November 5, 2019
·
6 min read
IMV to Present Clinical Translational Data from DeCidE1 Study of DPX-Survivac at SITC 2019 Annual Meeting

Robust survivin-specific T cell responses observed in recurrent late-stage ovarian cancer in nearly all evaluable subjects

November 5, 2019
·
6 min read
Business

Aptinyx to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, announced that the company will host a conference call and live webcast on Tuesday, November 12, 2019 at 5:00 p.m. EST to report third quarter 2019 financial results and discuss recent business highlights.

November 5, 2019
·
1 min read
Drug Development

Compugen Presents Preclinical Data for COM902 Anti-TIGIT Program at SITC 2019

Data support potential clinical use as a cancer immunotherapy treatment in various combinations with COM701 and PD-1 inhibitors

November 5, 2019
·
5 min read